Clinical Neurophysiology
Volume 121, Issue 4 , Pages 459-460 , April 2010

Copper toxicity in the general population

,Accepted 13 December 2009.

References 

  1. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson’s disease with zinc: XV long-term follow-up studies. J Lab Clin Med. 1998;132(4):264–278
  2. Brewer GJ, Newsome DA. Copper proof: chronic copper toxicity and the epidemics of Alzheimer’s disease and dementia. Ann Arbor, MI: George J. Brewer, Inc.; 2009;
  3. Hill GM, Brewer GJ, Juni JE, Prasad AS, Dick RD. Treatment of Wilson’s disease with zinc. II. Validation of oral 64 copper with copper balance. Am J Med Sci. 1986;292(6):344–349
  4. Morris MC, Evans DA, Tangney CC, Bienias JL, Schneider JA, Wilson RS, et al. Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol. 2006;63(8):1085–1088
  5. Salustri C, Barbati G, Ghidoni R, Quintiliani L, Ciappina S, Binetti G, et al. Is cognitive function linked to serum free copper levels? A cohort study in a normal population. Clin Neurophysiol. 2010;121(4):502–507
  6. Sparks DL, Schreurs BG. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer’s disease. Proc Natl Acad Sci USA. 2003;100(19):11065–11069
  7. Sparks DL, Friedland R, Petanceska S, Schreurs BG, Shi J, Perry G, et al. Trace copper levels in the drinking water, but not zinc or aluminum, influence CNS Alzheimer-like pathology. J Nutr Health Aging. 2006;10(4):247–254
  8. Squitti R, Pasqualetti P, Dal Forno G, Moffa F, Cassetta E, Lupoi D, et al. Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology. 2005;64(6):1040–1046
  9. Squitti R, Barbati G, Rossi L, Ventriglia M, Dal Forno G, Cesaretti S, et al. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau. Neurology. 2006;67(1):76–82
  10. Squitti R, Bressi F, Pasqualetti P, Bonomini C, Ghidoni R, Binetti G, et al. Longitudinal prognostic value of serum “free” copper in patients with Alzheimer disease. Neurology. 2009;72(1):50–55

PII: S1388-2457(09)00784-6

doi: 10.1016/j.clinph.2009.12.015

Clinical Neurophysiology
Volume 121, Issue 4 , Pages 459-460 , April 2010

Article Tools